Treating sleep apnea in patients using phrenic nerve stimulation
AssigneePacesetter, Inc.
InventorsEric Falkenberg, Mark W. Kroll
Life of this patent
Estimating the term…
Loading patent…
AssigneePacesetter, Inc.
InventorsEric Falkenberg, Mark W. Kroll
Estimating the term…
An exemplary implantable cardiac device is programmed to administer pacing therapy that treats both congestive heart failure (CHF) and sleep apnea. To treat CHF, the exemplary device delivers pacing pulses of a first voltage level via a lead in the left-sided veins of the heart. During periods of apnea, the device occasionally increases the pulse voltage and delivers one or more phrenic nerve stimulation pulses via the same lead to stimulate the phrenic nerve. This awakens the respiratory system to minimize or prevent episodes of sleep apnea. In an exemplary method, one or more phrenic nerve stimulation pulses are applied in synchronization with the pacing frequency so that the sleep apnea therapy does not disturb the normal cardiac rhythm. Other exemplary devices and methods are also disclosed.
An implantable cardiac device comprising:
An implantable cardiac device comprising:
An implantable cardiac device comprising:
An implantable and programmable cardiac device having a memory and a processor, the cardiac device being programmed to perform tasks comprising:
A method implemented by an implantable cardiac device, comprising:
A method comprising:
A method comprising:
Dependencies are inferred from the claim text.